Question 86

Lokelma is indicated to treat hyperkalemia.

Lokelma is specifically designed to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. It works by binding potassium in the gastrointestinal tract, thereby reducing its absorption and helping to lower serum potassium levels.

A) Levoxyl

Levoxyl is a brand name for levothyroxine, a medication used to treat hypothyroidism, not hyperkalemia. It functions as a thyroid hormone replacement and has no role in managing potassium levels.

B) Loperamide

Loperamide is an antidiarrheal medication that slows down gut movement to decrease the frequency of bowel movements. It does not have any effect on potassium levels and is therefore not indicated for treating hyperkalemia.

C) Levetiracetam

Levetiracetam is an anticonvulsant used primarily to treat seizures in epilepsy. This medication does not address potassium levels and is not indicated for the treatment of hyperkalemia.

D) Lokelma

Lokelma is a sodium zirconium cyclosilicate that is specifically indicated for the treatment of hyperkalemia. It effectively lowers potassium levels in patients by binding potassium in the intestines.

Conclusion

Lokelma is the definitive treatment for hyperkalemia due to its mechanism of binding potassium and reducing its absorption in the body. In contrast, the other options—Levoxyl, Loperamide, and Levetiracetam—are unrelated to potassium management, reinforcing that they are not suitable for treating hyperkalemia.